Repligen (RGEN) Gains from Investment Securities (2013 - 2026)

Repligen (RGEN) has reported Gains from Investment Securities for 9 consecutive years, with $2.3 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Gains from Investment Securities rose 129.07% year-over-year to $2.3 million; the TTM figure through Jun 2026 stood at -$3.5 million (up 26.16% YoY), while the FY2025 annual figure was -$13.6 million, down 526.42% from the prior year.
• Gains from Investment Securities grew to $2.3 million in Q2 2026 per RGEN's latest filing, from -$146000.0 in the prior quarter.
• Across five years, Gains from Investment Securities topped out at $3.2 million in Q4 2024 and bottomed at -$34.3 million in Q3 2023.
• Historically, Gains from Investment Securities has averaged -$4.8 million across 5 years, with a median of -$1.9 million in 2022.
• Annual changes were most pronounced in 2023 — Gains from Investment Securities sank 1385.15% — and 2024, when it soared 357.82%.
• Repligen's Gains from Investment Securities stood at -$17.1 million in 2022, then surged by 104.07% to $697000.0 in 2023, then jumped by 357.82% to $3.2 million in 2024, then slumped by 147.63% to -$1.5 million in 2025, then surged by 251.84% to $2.3 million in 2026.
• Business Quant data shows RGEN's Gains from Investment Securities at $2.3 million in Q2 2026, -$146000.0 in Q1 2026, and -$1.5 million in Q4 2025.